值得注意的是，晶泰科技原有业务几乎都在生物医药领域，和协鑫集团的合作，被外界视为一次巨大跨界。晶泰科技联合创始人、董事长温书豪表示，和协鑫集团的合作，为晶泰科技带来了一个重要的新增长曲线。温书豪同时表示，在全球范围内，晶泰科技也是第一家在新材料领域拿到如此重量级订单的AI公司。他透露，近期晶泰科技还在与其他国家和地区的新材料企业洽谈合作。Crystal Tai Technology-P (02228) rose more than 7% in the morning session, as of the time of publication, up 5.48% to HK$11.18, with a turnover of 8.4022 million Hong Kong dollars.
According to the Wisdom Financial APP, Crystal Tai Technology-P (02228) rose by more than 7% in the morning session, up 5.48% to HK$11.18 as of the time of publication, with a turnover of 8.4022 million Hong Kong dollars.
On the news front, at the end of August this year, Crystal Tai Technology announced the official signing of a 5-year strategic cooperation agreement with Xinjiang Xinte Group. According to the agreement, Xinjiang Xinte will gradually pay Crystal Tai Technology an estimated RMB 0.135 billion (approximately USD 1 billion) in research and development expenses according to the project research and development progress. It is reported that Crystal Tai Technology will provide Xinjiang Xinte with order-based services for high-tech new energy materials research and development in the fields of perovskite, supramolecular, lithium-ion batteries, cathode materials, and carbon-silicon materials.
It is worth noting that Crystal Tai Technology's original business was almost all in the biomedical field, and the cooperation with Xinjiang Xinte Group is seen by the outside world as a huge cross-border move. Wen Shuhao, co-founder and director of Crystal Tai Technology, stated that the cooperation with Xinjiang Xinte Group has brought about an important new growth curve for Crystal Tai Technology. Wen Shuhao also mentioned that globally, Crystal Tai Technology is the first AI company to secure such a heavyweight order in the new materials sector. He revealed that recently, Crystal Tai Technology has also been in discussions with new materials companies from other countries and regions.
